Refractory Breast Carcinoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12565	Abexinostat	1	Withdrawn	1
DB03166	Acetic acid	1	Recruiting	1
DB12015	Alpelisib	1	Completed	1
DB05015	Belinostat	1	Suspended	1
DB08889	Carfilzomib	1	Suspended	1
DB12483	Copanlisib	1	Suspended	1
DB09331	Daratumumab	1	Suspended	1
DB08899	Enzalutamide	1	Completed	1
DB01590	Everolimus	1	Completed	1
DB09502	Fludeoxyglucose (18F)	1	Suspended	1
DB13134	Fluorine F-18	1	Suspended	1
DB00947	Fulvestrant	1	Withdrawn	1
DB00441	Gemcitabine	1	Suspended	1
DB01006	Letrozole	1	Completed	1
DB09035	Nivolumab	1	Suspended	1
DB08935	Obinutuzumab	1	Suspended	1
DB09073	Palbociclib	1	Withdrawn	1
DB09037	Pembrolizumab	1	Suspended	1
DB00073	Rituximab	1	Suspended	1
DB06176	Romidepsin	1	Suspended	1
DB00072	Trastuzumab	1	Completed	1
DB00072	Trastuzumab	1	Recruiting	1
DB00072	Trastuzumab	1	Suspended	1
DB00531	Cyclophosphamide	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Withdrawn	1
DB00062	Albumin human	2	Active Not Recruiting	1
DB12015	Alpelisib	2	Active Not Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB01101	Capecitabine	3	Recruiting	1
DB08871	Eribulin	3	Recruiting	1
DB00441	Gemcitabine	3	Recruiting	1
DB00361	Vinorelbine	3	Recruiting	1